These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27330017)

  • 1. Newer tests for hepatitis C virus could transform screening.
    Wise J
    BMJ; 2016 Jun; 353():i3420. PubMed ID: 27330017
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prospect on the technique of test for blood donor infected with hepatitis C virus during the infectious window period].
    Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):159-60. PubMed ID: 11983147
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
    Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
    Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
    Lombardi GR; Oviedo A; Freytes F; Zarzur J; Guglielmone H; Vitali MS
    Transfus Med; 2008 Oct; 18(5):317-9. PubMed ID: 18937742
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pool tests for detection of hepatitis C virus infection.
    Fernandez E; Riestra S; Garcia S; Rodriguez S
    J Hepatol; 1995 Aug; 23(2):236. PubMed ID: 7499803
    [No Abstract]   [Full Text] [Related]  

  • 10. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
    Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
    Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
    Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-hepatitis C virus screening to prevent hepatitis C virus infection in blood donors].
    Sun Y; Zhao Y; Liu X
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):696-9. PubMed ID: 8731835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hepatitis C virus infection in adults.
    Rich JD; Taylor LE; Allen SA
    Ann Intern Med; 2004 Oct; 141(7):575-6; author reply 576. PubMed ID: 15466778
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus stability: the issue!
    Cardoso MS; Koerner K; Hinz W; Lenz C; Schwandt A; Kubanek B
    Vox Sang; 1999; 76(2):124-7. PubMed ID: 10085530
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
    Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
    Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.